Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
NCT06870812 · View on ClinicalTrials.gov ↗
Study Summary
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.
Conditions Studied
Interventions
- OTHER Medical Management
- PROCEDURE Surgical management
Study Locations (20)
Florida
- Baptist Health Jacksonville FL — Jacksonville
- Baptist Health South Florida — Kendall
- Jackson Memorial Hospital (JMH) — Miami
Georgia
- Grady Memorial Hospital — Atlanta
- Emory Hospital Midtown — Atlanta
- Emory University Hospital (EUH) — Atlanta
New York
- Albany Medical Center — Albany
- SUNY Upstate Medical University — Syracuse
- Montefiore Medical Center/Albert Einstein School of Medicine — The Bronx
Illinois
- Rush University — Chicago
- Endeavor Health, Northshore — Evanston
Ohio
- The Ohio State University — Columbus
- ProMedica Toledo Hospital — Toledo
Arkansas
- University of Arkansas for Medical Sciences — Little Rock
California
- Stanford University Medical Center — Palo Alto
Indiana
- Goodman Campbell Brain and Spine — Carmel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2030-03 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06870812
The ClinicalTrials.gov registry entry for NCT06870812 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,434 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Stroke Hemorrhagic appearing as the primary indexed condition, and to 2 interventions — of which Medical Management is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06870812 reports 20 study locations spanning 12 distinct geographic areas — top geographies include Florida, Georgia, New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06870812 about?
NCT06870812 is a clinical study titled "Rapid Evacuation and Access of Cerebral Hemorrhage Trial". The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medi...
What is the current status of trial NCT06870812?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-05-27. Estimated completion is 2030-03.
What conditions does trial NCT06870812 study?
This clinical trial studies the following conditions: Stroke Hemorrhagic. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06870812?
The interventions under investigation include: Medical Management (OTHER), Surgical management (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06870812?
This trial is sponsored by Emory University, which has 1,434 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06870812 being conducted?
This trial has 20 study locations across Arkansas, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.